Santhera Pharmaceuticals announced a strategic change to its management team with the appointment of Dario Eklund as CEO, effective December 1, 2019. Thomas Meier will continue as a Board Member and will chair the newly formed Board of Director's Scientific Committee. He will also serve as a special advisor to Dario Eklund, ensuring a smooth transition in Santhera's leadership.

Dario Eklund joins Santhera from Vifor Pharma, where he most recently served as Chief Commercial Officer with full P&L responsibility for a global business with turnover in excess of CHF 1 billion and more than 1'000 employees. He was a member of Vifor's Corporate Executive Committee and a member of the Board of Directors of the joint venture with Fresenius Medical Care. Prior to Vifor, Dario spent a decade in Boston as Vice President and a member of the Executive Committee at Organogenesis Inc.